Silgan Dispensing has expanded the reach of its ERA dispensing platform, adding airless packaging formats and introducing new tube sizes.
Initially introduced in 2025 for facial and sun care products in 30mm and 40mm tubes, the ERA line now includes integration with the company’s DNA airless systems.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The DNA 35ERA is designed for products such as facial serums and creams and offered in 30ml, 40ml, and 50ml formats.
Silgan Dispensing said that this range aligns with future regulatory requirements and focuses on features such as “controlled actuation”, compatibility with various formulations, “precise” dosing, and protection using airless technology.
The new ERA airless system is reported to have a formula evacuation rate above 95%, aiming to minimise product residue and packaging waste.
The second development adapts the ERA platform for smaller-capacity cosmetic tubes with 25mm and 30mm diameters for products such as liquid makeup and targeted treatments.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe platform also incorporates Silgan Dispensing’s LifeCycle technology, which replaces metal springs with plastic to improve recyclability.
Silgan Dispensing provides dispensing solutions, including triggers, pumps, sprayers, and closures for consumer goods companies in the home, health, and beauty sectors.
Silgan Holdings’ net income in the fourth quarter of 2025 was $18.2m, compared with $45.1m for the same period in the previous year.
Quarterly net sales reached $1.47bn, marking a 4% year-on-year rise.
This increase was attributed to the contractual pass-through of higher raw material costs and positive changes in currency exchange rates, according to the rigid packaging supplier.
For the full year 2025, Silgan reported net income of $288.4m, compared to $276.4m in 2024.
